Skip to content

Oral midazolam versus intranasal Dexmedetomidine for CT imaging in children

Comparison of oral midazolam with intranasal Dexmedetomidine premedication for children undergoing CT imaging: randomized, double blind and controlled study

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/03/004456
Enrollment
48
Registered
2014-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pediatric patients visiting hospital for diagnostic CT Imaging

Interventions

Intervention1: Dexmedetomidine group (Group D): 2.5 mc/Kg intranasal dexmedetomidine and oral honey 5 ml 20-30 minutes before venepuncture Control Intervention1: Midazolam group (group M): 0.5 mg/Kg m

Sponsors

Post Graduate Institute of Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I or II children aged 1 â?? 5 years scheduled for CT imaging under sedation

Exclusion criteria

Exclusion criteria: Children with history of allergy to eutectic mixture of local anesthetic (EMLA) cream, midazolam severe dysfunction of central nervous system, malformation of cardiovascular system, children on chronic hepatic enzyme inducing drugs or mentally retarded children

Design outcomes

Primary

MeasureTime frame
incidence of children requiring rescue sedation (IV ketamine)Timepoint: during CT Imaging

Secondary

MeasureTime frame
incidence of children crying at venipuncture, number of attempts at venipuncture, sedation and venipuncture scores, requirement of ketamine for CT, parental satisfaction, movements and motion artifacts during scan and requirement of repeat scanTimepoint: at venepuncture and during CT imaging

Countries

India

Contacts

Public ContactDr Babita Ghai

Post Graduate Institute of Medical Education and Research, Chandigarh

ghaibabita@hotmail.com9914209533

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026